Incidence of Donor-Specific Antibodies in Kidney-Transplant Patients Receiving an Everolimus-Based, Calcineurin Inhibitor-Free Immunosuppressive Regimen.

被引：0
|
作者：
Kamar, N. [1 ]
Fort, M. [2 ]
Cardeau-Desangles, I. [1 ]
Congy, N. [1 ]
Esposito, L. [1 ]
Guitard, J. [1 ]
Rostaing, L. [1 ]
机构：
[1] Toulouse Univ Hosp, Dept Nephrol Dialysis & Organ Transplantat, Toulouse, France
[2] Toulouse Univ Hosp, Dept Immunol, Toulouse, France
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2011年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
1302
引用
收藏
页码：409 / 410
页数：2
相关论文
共 45 条
  • [1] Incidence of donor-specific antibodies in kidney transplant patients following conversion to an everolimus-based calcineurin inhibitor-free regimen
    Kamar, Nassim
    Del Bello, Arnaud
    Congy-Jolivet, Nicolas
    Guilbeau-Frugier, Celine
    Cardeau-Desangles, Isabelle
    Fort, Marylise
    Esposito, Laure
    Guitard, Joelle
    Game, Xavier
    Rostaing, Lionel
    [J]. CLINICAL TRANSPLANTATION, 2013, 27 (03) : 455 - 462
  • [2] Effect of Calcineurin Inhibitor-Free, Everolimus-Based Immunosuppressive Regimen on Albuminuria and Glomerular Filtration Rate After Heart Transplantation
    Nelson, Laerke Marie
    Andreassen, Arne Kristian
    Andersson, Bert
    Gude, Einar
    Eiskjaer, Hans
    Radegran, Goran
    Dellgren, Goran
    Gullestad, Lars
    Gustafsson, Finn
    [J]. TRANSPLANTATION, 2017, 101 (11) : 2793 - 2800
  • [3] Sotrastaurin in Calcineurin Inhibitor-Free Regimen Using Everolimus in De Novo Kidney Transplant Recipients
    Tedesco-Silva, H.
    Kho, M. M. L.
    Hartmann, A.
    Vitko, S.
    Russ, G.
    Rostaing, L.
    Budde, K.
    Campistol, J. M.
    Eris, J.
    Krishnan, I.
    Gopalakrishnan, U.
    Klupp, J.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 (07) : 1757 - 1768
  • [4] Cognitive functioning among heart transplant recipients, receiving calcineurin inhibitor-free, everolimus-based immunosuppression since the early postoperative phase
    Burker, B. S.
    Andersson, S.
    Gullestad, L.
    Gude, E.
    Relbo, A.
    Grov, I.
    Malt, U. F.
    Andreassen, A.
    Fiane, A. E.
    Haraldsen, I. R.
    [J]. JOURNAL OF PSYCHOSOMATIC RESEARCH, 2015, 78 (06) : 595 - 596
  • [5] Treatment of De Novo Renal Transplant Recipients With Calcineurin Inhibitor-free, Belatacept Plus Everolimus-based Immunosuppression
    Peddi, V. Ram
    Marder, Bradley
    Gaite, Luis
    Oberholzer, Jose
    Goldberg, Ryan
    Pearson, Thomas
    Yang, Harold
    Allamassey, Lisa
    Polinsky, Martin
    Formica, Richard N.
    [J]. TRANSPLANTATION DIRECT, 2023, 9 (02): : E1419
  • [6] Alemtuzumab Preconditioning Allows Steroid-calcineurin Inhibitor-free Regimen in Live-donor Kidney Transplant
    Refaie, Ayman F.
    Mahmoud, Khaled M.
    Ismail, Amani M.
    Sheashaa, Hussein A.
    Kamal, Ahmed I.
    Ghoneim, Mohamed A.
    [J]. EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2011, 9 (05) : 295 - 301
  • [7] Subclinical Lesions and Donor-Specific Antibodies in Kidney Transplant Recipients Receiving Tacrolimus-Based Immunosuppressive Regimen Followed by Early Conversion to Sirolimus
    de Sandes-Freitas, Taina Veras
    Felipe, Claudia Rosso
    Campos, Erika Fernandes
    de Lima, Maria Gerbasi
    Soares, Maria Fernanda
    de Franco, Marcello Fabiano
    Aguiar, Wilson Ferreira
    Tedesco-Silva, Helio
    Medina-Pestana, Jose Osmar
    [J]. TRANSPLANTATION, 2015, 99 (11) : 2372 - 2381
  • [8] Impact of calcineurin inhibitor-free immunosuppression on de novo donor-specific antibody formation in liver transplant recipients
    Meszaros, Magdalena
    Dubois, Valerie
    Congy-Jolivet, Nicolas
    Hamada, Sarah
    Thevenin, Celine
    Faure, Stephanie
    Boillot, Olivier
    Kamar, Nassim
    Pageaux, Georges-Philippe
    Del Bello, Arnaud
    Dumortier, Jerome
    [J]. LIVER INTERNATIONAL, 2022, 42 (05) : 1132 - 1143
  • [9] Conversion to Everolimus-Based Immunosuppression Regimen with Calcineurin Inhibitor Reduction Ameliorates Histological Damage in Kidney Transplant Recipients with Calcineurin Inhibitor-Induced Nephrotoxicity.
    Hotta, K.
    Iwahara, N.
    Tanabe, T.
    Shinohara, N.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 1083 - 1083
  • [10] Sirolimus-based, calcineurin inhibitor-free regimen in kidney transplant patients: An open-label, randomized, controlled trial
    El-Agroudy, Amgad E.
    Al Arrayed, Sameer M.
    Al-Ghareeb, Sumaya M.
    Farid, Eman
    Alhelow, Hamad
    Abdulla, Sadiq
    [J]. EUROPEAN JOURNAL OF GENERAL MEDICINE, 2016, 13 (03): : 16 - 22
12345